Latest Blog Posts for Mesothelioma Blog Article

• Measuring Mesothelioma Treatment Response with Biomarkers
  on Dec 2, 2016 in Measuring Mesothelioma Treatment Response with Biomarkers
  Malignant pleural mesothelioma is notoriously difficult to treat and doctors often have to try different treatment combinations to produce a response. But how can they know if a particular treatment strategy is working?A team of researchers...
• Mesothelioma Risk Among Seaman and Sailors Still Hard to Quantify
  on Dec 2, 2016 in Mesothelioma Risk Among Seaman and Sailors Still Hard to Quantify
  Thousands of people who worked aboard commercial ships may be at higher risk for developing malignant mesothelioma.Unfortunately, although the mesothelioma risk for merchant seamen has been acknowledged since the 1970s, there...
• Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival
  on Dec 2, 2016 in Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival
  A large US study of mesothelioma patients confirms what other studies have suggested: Mesothelioma patients who havechemotherapy live longer than those who don’t, and multimodal therapy is the best way to improve overall mesothe...
• Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival
  on Dec 2, 2016 in Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival
  There has been some encouraging news this month for patients suffering from an aggressive form of lung cancer called malignant pleural mesothelioma. New research suggests that, even in patients with advanced mesothelioma, long-term survival...
• Platelet Count May be an Effective Tool for Mesothelioma Prognosis
  on Dec 2, 2016 in Platelet Count May be an Effective Tool for Mesothelioma Prognosis
  A high platelet count may not bode well for people battlingmalignant pleural mesothelioma.New evidence suggests that people who have a high concentration of platelets in their blood prior to the start of mesothelioma treatmen...
• New Mesothelioma Immunotherapies Target Key Protein
  on Dec 2, 2016 in New Mesothelioma Immunotherapies Target Key Protein
  The cell-surface glycoprotein mesothelin is poised to be a key part of several new immunotherapy approaches for the treatment of malignant pleural mesothelioma, a treatment-resistant cancer caused by asbestos.A team of top mesothe...
• Psychological Needs of Mesothelioma Patients Differ from Lung Cancer
  on Dec 2, 2016 in Psychological Needs of Mesothelioma Patients Differ from Lung Cancer
  New research suggests that, even though pleural mesothelioma is considered a type of lung cancer, people with the asbestos cancer are likely to face some different stresses and concerns from lung cancer patients.Pleural mesothelio...
• New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis
  on Dec 2, 2016 in New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis
  New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma DiagnosisMalignant mesothelioma is not only one of the rarest and most difficult-to-treat cancers. It is also among the hardest to diagnose.The challenge of diagno...
• Asbestos-Related T-Cell Changes Help Explain Mesothelioma Developmen
  on Dec 2, 2016 in Asbestos-Related T-Cell Changes Help Explain Mesothelioma Developmen
  Researchers in Japan have taken another step toward understanding how asbestos causes malignant mesothelioma.Exposure to airborne asbestos fibers is the leading cause of malignant mesothelioma worldwide, but sc...
• Swedish Mesothelioma Rates Unaffected By Asbestos Ban
  on Dec 2, 2016 in Asbestos mesothelioma Swedish Mesothelioma Rates Unaffected By Asbestos Ban
  The asbestos ban instituted in Sweden more than 30 years ago had still not had any measurable impact on the incidence ofmalignant mesothelioma in the country as of 2009.That is the conclusion reached by researchers at Sweden’s I...

{pvComments::user_name}

{pvComments::date}

Delete 

{pvComments::comment}

Post a Comment